1,115 results on '"Goldstein, Alisa M."'
Search Results
2. Genomic profiles and clinical presentation of chordoma
3. Genome-wide analyses characterize shared heritability among cancers and identify novel cancer susceptibility regions
4. Inflated expectations: Rare-variant association analysis using public controls
5. Impact of Transcript (p16/p14ARF) Alteration on Cancer Risk in CDKN2A Germline Pathogenic Variant Carriers.
6. CSMD1 Shows Complex Patterns of Somatic Copy Number Alterations and Expressions of mRNAs and Target Micro RNAs in Esophageal Squamous Cell Carcinoma
7. The Mutographs biorepository: A unique genomic resource to study cancer around the world
8. Novel MAPK/AKT-impairing germline NRAS variant identified in a melanoma-prone family
9. Integrated Analysis of Coexpression and Exome Sequencing to Prioritize Susceptibility Genes for Familial Cutaneous Melanoma
10. First international workshop of the ATM and cancer risk group (4-5 December 2019)
11. Kinetics of EBV antibody‐based NPC risk scores in Taiwan NPC multiplex families.
12. Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence
13. Germline Mutations in PALB2, BRCA1, and RAD51C, Which Regulate DNA Recombination Repair, in Patients With Gastric Cancer
14. Molecular Characterization of the Human Stomach Microbiota in Gastric Cancer Patients
15. A systematic review of the prevalence of germline pathogenic variants in patients with pancreatic cancer
16. Low Epstein–Barr Virus Prevalence in Cardia Gastric Cancer Among a High-Incidence Chinese Population
17. Variation in Cutaneous Patterns of Melanomagenesis According to Germline CDKN2A/CDK4 Status in Melanoma-Prone Families
18. Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome
19. ABO genotypes and the risk of esophageal and gastric cancers
20. Whole genome sequencing of skull-base chordoma reveals genomic alterations associated with recurrence and chordoma-specific survival
21. Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility
22. Gene-Level Associations in Patients With and Without Pathogenic Germline Variants in CDKN2A and Pancreatic Cancer
23. Assessing the Incremental Contribution of Common Genomic Variants to Melanoma Risk Prediction in Two Population-Based Studies
24. Atypical Spitz tumor with SQSTM1::NTRK2 fusion: Report of a case with unique spindled cell features.
25. Estimated Prevalence, Tumor Spectrum, and Neurofibromatosis Type 1–Like Phenotype of CDKN2A-Related Melanoma-Astrocytoma Syndrome
26. Risks of Melanoma and Other Cancers in Melanoma-Prone Families over 4 Decades
27. Using whole-exome sequencing and protein interaction networks to prioritize candidate genes for germline cutaneous melanoma susceptibility
28. Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families
29. Chordoma: Incidence and Survival Patterns in the United States, 1973-1995
30. Increased frequency of CHEK2 germline pathogenic variants among individuals with dermatofibrosarcoma protuberans
31. Phenocopies in melanoma-prone families with germ-line CDKN2A mutations
32. Second Cancers after Medulloblastoma: Population-Based Results from the United States and Sweden
33. Supplementary Material 2 from A Gene Expression Signature from Peripheral Whole Blood for Stage I Lung Adenocarcinoma
34. Data from A Gene Expression Signature from Peripheral Whole Blood for Stage I Lung Adenocarcinoma
35. Supplementary Material 1 from A Gene Expression Signature from Peripheral Whole Blood for Stage I Lung Adenocarcinoma
36. Data from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
37. Supplementary fig 2 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
38. Supplementary fig 4 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
39. Supplementary Legend 1 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
40. Supplementary fig 3 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
41. Supplementary fig 1 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
42. Supplementary fig 5 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
43. Table S1-S5 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
44. Data from MicroRNA Expression Differentiates Histology and Predicts Survival of Lung Cancer
45. Data from Genomic Landscape of Somatic Alterations in Esophageal Squamous Cell Carcinoma and Gastric Cancer
46. Supplementary table 8 from Genomic Landscape of Somatic Alterations in Esophageal Squamous Cell Carcinoma and Gastric Cancer
47. Supplementary table 6 from Genomic Landscape of Somatic Alterations in Esophageal Squamous Cell Carcinoma and Gastric Cancer
48. Supplementary table 2 from Genomic Landscape of Somatic Alterations in Esophageal Squamous Cell Carcinoma and Gastric Cancer
49. Supplementary table 4 from Genomic Landscape of Somatic Alterations in Esophageal Squamous Cell Carcinoma and Gastric Cancer
50. Table Legend from Genomic Landscape of Somatic Alterations in Esophageal Squamous Cell Carcinoma and Gastric Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.